Skip to content
Recall Observatory FDA recall evidence

Drug product

Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, Packaged in a) 100-count bottle, NDC 70010-780-01; b) 500-count bottle, NDC 70010-780-05; Rx only, Manufactured by: Granules India Limited, Hyderadab-500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA 20151,

D-0510-2025

June 24, 2025

Class II

Product summary

Firm
Granules Pharmaceuticals Inc.
Event
Event 97131
Status
Ongoing
Classification
Class II
Quantity
27,648 100-count Bottles; 5,376 500-count Bottles
Official record key
drug-enforcement:D-0510-2025

Official wording

Reason: Failed Dissolution Specifications: Product failed to meet dissolution acceptance criteria in the stability studies at the 6th month (25¿C/60% RH) long-term.

Code information: Lot # a)1400008A, Exp Date: 12/31/2025; b) 1400008B, Exp Date: 12/31/2025

Distribution pattern: Nationwide in the USA.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Dissolution Specifications